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Staphylococcus epidermidis biofilm formation on indwelling medical devices is frequently
associated with the development of chronic infections. Nevertheless, it has been
suggested that cells released from these biofilms may induce severe acute infections
with bacteraemia as one of its major associated clinical manifestations. However, how
biofilm-released cells interact with the host remains unclear. Here, using a murine model
of hematogenously disseminated infection, we characterized the interaction of cells
released from S. epidermidis biofilms with the immune system. Gene expression analysis
of mouse splenocytes suggested that biofilm-released cells might be particularly effective
at activating inflammatory and antigen presenting cells and inducing cellular apoptosis.
Furthermore, biofilm-released cells induced a higher production of pro-inflammatory
cytokines, in contrast to mice infected with planktonic cells, even though these had a
similar bacterial load in livers and spleens. Overall, these results not only provide insights
into the understanding of the role of biofilm-released cells in S. epidermidis biofilm-related
infections and pathogenesis, but may also help explain the relapsing character of these
infections.
Keywords: S. epidermidis, biofilms, biofilm-released cells, splenocytes transcriptome, pro-inflammatory
cytokines, tissue colonization
INTRODUCTION
Staphylococcus epidermidis is one of the most important etiological agents of device-associated
infections due to its ability to adhere and form biofilms on the surface of indwelling
medical devices (Vuong and Otto, 2002; Otto, 2009). When compared to planktonic cells,
S. epidermidis cells within biofilms are known to be more tolerant to several classes of
antibiotics (Cerca et al., 2005), as well as to the host immune effectors (Cerca et al.,
2006; Kristian et al., 2008). Biofilms represent therefore a common cause of recurrent and
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relapsing infections (Costerton et al., 1999). Consequently,
removal of the infected devices is often required to resolve these
infections (von Eiff et al., 2002), which results in increased
morbidity and, occasionally, mortality among infected patients
(Otto, 2009). Due to the enormous impact of S. epidermidis
biofilm-related infections on human health, the mechanisms
underlying biofilm formation have been extensively studied
in the last decades. It is currently accepted that biofilm
formation involves three main stages: (1) initial adhesion,
(2) maturation, and (3) disassembly (Otto, 2012). The later
refers to the release of bacterial cells from the biofilm to the
surrounding environment, and is the least understood stage of
the biofilm lifecycle (Boles and Horswill, 2011). Importantly,
biofilm disassembly has been associated with the emergence
of severe acute infections such as bacteraemia (Wang et al.,
2011) and the embolic events of endocarditis (Pitz et al.,
2011). However, despite its clear importance in the clinical
setting, little is known regarding the phenotype or interaction
of these cells with the host immune system. In the first stages
of biofilm formation, planktonic bacteria attached to medical
devices undergo several physiological modifications that lead to
the biofilm phenotype (Yao et al., 2005). Thus, it was thought
that after disassembly biofilm-released cells would quickly
revert to the planktonic phenotype (Kaplan, 2010; Chua et al.,
2014). However, recent reports have shown that cells released
from Pseudomonas aeruginosa (Rollet et al., 2009; Li et al.,
2014), Streptococcus mutans (Liu et al., 2013), and Streptococcus
pneumoniae (Marks et al., 2013) biofilms present features distinct
from either the biofilm or planktonic phenotypes, showing
higher virulence potential. Chua and collaborators showed that
P. aeruginosa biofilm-released cells, when compared with their
planktonic or biofilm counterparts, present higher expression
level of genes associated with the bacterium virulence, namely
Type 2 Secretion System (TSS) and T3SS psc gene and, more
important, they showed that these genes are essential in eliciting
full virulence against macrophages and in the rapid killing of
Caenorhabditis elegans (Chua et al., 2014), respectively. In the
case of S. epidermidis, it is only known that biofilm-released
cells present higher tolerance than planktonic and biofilm
cells to antibiotics (Franca et al., 2016). However, their full
virulence potential remains unclear. A comprehensive analysis
of the interaction between biofilm-released cells and the host
would clarify their role in the pathogenesis of biofilm-related
infections, and help to prevent the pathologic events associated
with biofilm cells dissemination. Therefore, herein, a murine
model of hematogenously disseminated infection was used to
evaluate the capacity of S. epidermidis biofilm-released cells to
(1) induce changes in the transcriptome of murine immune
cells within the spleen, (2) stimulate the production of pro-
inflammatory cytokines, and (3) colonize and persist in murine
organs. Our results showed that S. epidermidis biofilm-released
cells induce a prompt and more marked inflammatory-type
response than do their planktonic or biofilm counterparts. In
addition, these findings showed that particular properties of the
biofilm-released cells need to be taken into account to efficiently
target and treat acute infections originating from S. epidermidis
biofilms.
MATERIALS AND METHODS
Ethics Statement
This study was performed in strict accordance with the
recommendations of the European Convention for the
Protection of Vertebrate Animals used for Experimental
and Other Scientific Purposes (ETS 123), the 86/609/EEC
directive and Portuguese rules (DL 129/92). All experimental
protocols were approved by the competent national authority
(Direcção-Geral de Veterinária), document 023517 (2010.11.25).
Mice
Female BALB/c mice, 8–12 weeks old, were purchased from
Charles River (Barcelona, Spain) and kept under specific-
pathogen-free conditions at the Animal Facility of the Instituto
de Ciências Biomédicas Abel Salazar, Porto, Portugal. Mice
were maintained in individually ventilated cages (5 animals per
cage) with corncob bedding, and under controlled conditions of
temperature (21± 1◦C), relative humidity (between 45 and 65%)
and light (12 h light/ dark cycle). Mice had ad libitum access to
food and water. Hiding and nesting materials were provided for
enrichment. All procedures such cage changing, water and food
supply, as well as intravenous injections were always performed
during the day cycle (between 7 and 19 h).
Bacteria and Growth Conditions
The biofilm forming strain S. epidermidis 9142, isolated from a
blood culture (Mack et al., 1994), was used in this study. A single
colony, from a Tryptic Soy Agar (TSA) plate, was inoculated
into 2mL of Tryptic Soy Broth (TSB, Liofilchem, Teramo, Italy)
and incubated overnight at 37◦C with shaking at 120 rpm. A
suspension with ∼1 × 108 CFU/mL, prepared by adjusting the
optical density (at 640 nm) of the overnight culture to 0.25 ±
0.05, was used to start both planktonic and biofilm cultures.
For planktonic cultures 150µL of 1 × 108 CFU/mL bacterial
suspension was inoculated into 10mL of TSB supplemented with
0.65% (v/v) glucose (TSB0.65%G) and incubated for 24 h at 37
◦C
under agitation at 120 rpm. Biofilms were grown in 24-well
plates made of polystyrene plastic (Orange Scientific, Braine-l’
Alleud, Belgium) by inoculating 15µL of the 1 × 108 CFU/mL
bacterial suspension into 1 mL of TSB0.65%G, then incubating at
37◦C with agitation at 120 rpm. After 24 h of growth, biofilms
were washed twice with apyrogenic Phosphate Buffered Saline
(PBS, Gibco, MD, USA), 1mL of fresh TSB0.65%G was carefully
added and biofilms allowed to grow, under the same temperature
and agitation conditions, for additional 24 h. Biofilm-released
cells, (i.e., the cells in the biofilm bulk-fluid), were collected as
described before (Franca et al., 2016) from 12 originating biofilms
and pooled together to decrease variability inherent to biofilm
growth (Sousa et al., 2014). Four biofilms were washed twice with
apyrogenic PBS, disrupted and also pooled together to reduce
variability. Planktonic (4mL of culture), biofilm and biofilm-
released cells were then harvested by centrifugation, suspended
in 4 mL of apyrogenic PBS (Gibco, MD, USA) and sonicated for
10 s at 18W (Branson modelW 185 D, Heat Systems Ultrasonics,
CT, USA) in order to dissociate cell clusters. Cells viability was
not reduced by this procedure as determined previously by
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CFU counting and propidium iodide incorporation (Cerca et al.,
2011).
Murine Model of Hematogenously
Disseminated Infection
The inoculum of each of the bacterial populations was adjusted
by flow cytometry to 5 × 108 total cells/mL, using SYBR Green
(LifeTechnologies, MD, USA)/propidium iodide (Sigma, MO,
USA) staining, as optimized before (Cerca et al., 2011). The
number of cultivable cells was assessed by CFU counting. Adult
mice, randomly allocated to each experimental group, were
injected intravenously in the lateral tail vein, with the support
of a restrainer, with 0.2mL of 5 × 108 of planktonic, biofilm
or biofilm-released cell suspensions. Control mice were injected
intravenously with 0.2mL of apyrogenic PBS. Sample size was
determined based on the results of preliminary experiments.
It was not possible to perform subsequent mouse studies in a
blinded fashion. In order to address the alterations occurring
during the acute phase of infection, the parameters evaluated in
this study were assessed 2, 6, or 14 h after challenging the three S.
epidermidis populations.
Serum Collection and Bacterial Load
Determination in Organs
Two, 6, and 14 h post-infection, mice were anesthetized with
isoflurane (Abbott laboratories, IL, USA) for terminal blood
collection, and then euthanized by cervical dislocation. For
serum collection, mouse blood was drawn through the retro-
orbital route, incubated overnight at 4◦C, and then centrifuged
for 15 min at 4◦C at 16,000 g. Serum was then transferred into
a new tube and stored at −80◦C until further use. Livers and
spleens were aseptically removed and immediately transferred
into tissue grinders with, respectively, 3 or 1mL of PBS. Tissues
were homogenized and quantitatively cultured on TSA plates.
At all times during the procedure, samples were kept on ice.
This experiment was performed 1 (for biofilms cells at all time
points) to 3 (planktonic and biofilm-released cells, 6 h time point)
independent times, with at least 5 animals per infected group.
Cytokines and Chemokines Quantification
Two, 6, and 14 h post-infection, the levels of the cytokines IL-6,
TNF-α and the chemokines CXCL1 (KC), CCL2 (MCP-1), CCL3
(MIP-1α), CCL4 (MIP-1β) in mouse serum were quantified in
a Bio-Plex R© 200 using the kit Magnetic Custom Multiplex Bio-
Plex ProTM Mouse Cytokine Group I assay (Bio-Rad, CA, USA).
The procedure was performed following the manufacturer’s
instructions. This experiment was performed 1 (all populations
at 6 and 14 h time point) to 2 (all populations at 2 h time point)
independent times, with at least 5 animals per infected group.
Microarray Analysis of Mouse Splenocytes
Spleen cells plays a major role in host immune response to blood-
born pathogens, working in concert to activate mechanisms
required for successful resolution of infection. Hence, in order
to address the mechanisms activated during the first contact
with the different S. epidermidis populations, the transcriptome
of splenocytes was analyzed, by microarrays, 2 h after challenge.
In brief, spleens were aseptically removed, transferred to
60mm diameter sterile Petri dishes with 9 mL apyrogenic PBS
and immediately placed on ice. Thereafter, using two sterile
frosted glass slides, spleens were completely homogenized. The
suspension was then passed through a sterile column of glass
wool to remove fibrous tissue, the number of cells counted
by flow cytometry, and 5 × 106 splenocytes harvested by
5 min centrifugation at 1200 rpm at 4◦C. Cell pellets were
immediately suspended in RLT buffer (QIAGEN, Heidelberg,
Germany) and stored at −80◦C until the next day. Total
RNA was then isolated using the RNeasy Mini Kit (QIAGEN)
following the manufacturer’s instructions. Concentration and
purity was determined using a NanoDropTM1000 and integrity
was confirmed using an Agilent 2100 Bioanalyzer (Agilent
Technologies, CA, USA). RNA integrity number values were
above 8.5 for all samples. This experiment was performed once
with 2 (control and planktonic cells) to 3 (biofilm and biofilm-
released cells) animals per group.
Transcription levels in mouse splenocytes were determined
using Affymetrix R© Mouse Gene 2.1 ST Array Strip (Affymetrix,
MA, USA). RNA was prepared for analysis using Ambion
WT Expression Kit (ThermoFisher Scientific, MA, USA) and
GeneChip R© WT Terminal Labeling Kit (Affymetrix). Briefly,
100 ng of total RNA, containing spiked in Poly-A RNA controls,
was used in a reverse transcription reaction to generate first-
strand complementary DNA. After second-strand synthesis,
double-stranded complementary DNA was used to generate
cRNA. cRNA (15µg) was then used for a second cycle of first-
strand cDNA synthesis and the resultant single stranded cDNA
(5.5µg) was fragmented and end-labeled. Size distribution of
the fragments was assessed using an Agilent 2100 Bioanalyzer
(Agilent Technologies). End-labeled, fragmented cDNA (3.5µg),
was then used in a 150µL hybridization cocktail containing
hybridization controls (GeneAtlas R© Hybridization, Wash, and
Stain Kit for WT Array Strips, Affymetrix), of which 120µL
were hybridized on array strips for 20 h at 48◦C. Standard post
hybridization wash and double-stain protocols were used on an
Affymetrix GeneAtlas system, followed by scanning of the array
strips.
Microarray Data Analysis
The arrays were analyzed using Chipster 2 (Kallio et al., 2011)
with a custom cdf file in mogene21stmmentrezg.db, as available
from Brainarray database (version 17; Sandberg and Larsson,
2007). Following Robust Multi-array Average normalization and
biomaRt annotation, differential expression was determined by
empirical Bayes two-group test (Smyth, 2004) with Benjamini-
Hochberg multiple testing correction and a P-value cut-off of
0.05. For further analyses, only genes with fold changes above 1.5
were included. The heatmap was constructed using matrix2png
interface (Pavlidis and Noble, 2003). Venn diagram, created
using VENNY 2.1 (Oliveros, 2007), was used to identify the
genes that were uniquely and commonly expressed in mice
infected with different S. epidermidis bacterial populations. Gene
ontology (GO) terms enrichment was assessed using the Search
Tool for the Retrieval of Interacting Genes/Proteins (STRING)
(version 10; Franceschini et al., 2013). Only gene-sets passing
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FIGURE 1 | Analysis of the transcriptome of the spleen of mice infected with different S. epidermidis populations. BALB/c mice were challenged
intravenously with 1 × 108 planktonic (P) (n = 2), biofilm (B) (n = 3), biofilm-released (BR) cells (n = 3), or sham-infected treated with PBS alone (PBS) (n = 2). Two
hours post-infection, spleens were collected and microarray analysis was performed. (A) Principal component analysis; (B) Number of genes with increased and
decreased transcription in each condition (P < 0.05, Empirical Bayes two-group test with Benjamini-Hochberg multiple testing correction). (C) Venn diagram showing
the number of genes that are commonly (overlapping circles) and uniquely expressed (non-overlapping circles) in each condition; (D) Heatmap of the differentially
expressed genes. White lines indicate non-detected genes or genes with no significant alterations (P > 0.05, Empirical Bayes two-group test with
Benjamini-Hochberg multiple testing correction).
significance thresholds (P < 0.05 with false discovery rate)
were selected for further analysis. To reduce redundancy, GO
terms found enriched in STRING were reanalyzed by REVIGO
(Supek et al., 2011), allowing for small (0.5) similarity, using
the species-specificMus musculus database (in order to fine-tune
the calculation of semantic distances which rely on information
contents of GO terms for this particular species) and SimRel
score. The complete list of the genes differentially and uniquely
expressed in splenocytes of mice infected with planktonic,
biofilm, or biofilm-released cells is available at GEO database
repositorium, under the accession number GSE60992.
Statistical Analysis
Statistical analysis was carried out with GraphPad Prism (CA,
USA). The normality of the data obtained was evaluated
using Kolmogorov–Smirnov test. Accordingly, Kruskal–Wallis
and Dunn’s multiple comparison tests were applied and
data depicted in median of all independent experiments.
Differences among groups were considered significant when
P < 0.05. Statistical differences found between planktonic
and biofilm cells phenotype were not indicated as the aim
of the study was not to compare the differences between
them. Statistical analysis used for microarrays data evaluation
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TABLE 1 | List of the top most transcribed genes in the spleen of mice infected with S. epidermidis planktonic, biofilm or biofilm-released cells.
Gene Description Fold change P-value
PLANKTONIC CELLS INFECTED MICE
Irg1 Immunoresponsive gene 1 39.08±4.02 < 0.001
Clec4e C-type lectin domain family 4, member e 17.46±4.73 0.004
Cxcl2 Chemokine (C-X-C motif) ligand 2 16.63±3.64 0.003
Cxcl10 Chemokine (C-X-C motif) ligand 10 8.73±2.98 0.012
Clec5a C-type lectin domain family 5, member a 7.80±0.92 0.003
Slc7a11 Solute carrier family 7, member 11 7.88±2.47 0.013
Ccrl2 Chemokine (C-C motif) receptor-like 2 7.20±0.67 0.006
Mmrgpra2a MAS-related GPR, member A2A 7.15±2.17 0.012
Gpr84 G protein-coupled receptor 84 6.31±1.23 0.009
IIl1rn Interleukin 1 receptor antagonist 5.93±0.95 0.008
BIOFILM-RELEASED CELLS INFECTED MICE
Irg1 Immunoresponsive gene 1 49.02±5.41 < 0.001
Cxcl2 Chemokine (C-X-C motif) ligand 2 25.90±3.85 < 0.001
Clec4e C-type lectin domain family 4, member e 20.24±0.24 < 0.001
Slc7a11 Solute carrier family 7, member 11 13.33±1.99 < 0.001
Mrgpra2a MAS-related GPR, member A2A 9.69±0.14 < 0.001
Ccrl2 Chemokine (C-C motif) receptor-like 2 8.83±1.03 < 0.001
Clec5a C-type lectin domain family 5, member a 8.52±1.10 < 0.001
Cxcl10 Chemokine (C-X-C motif) ligand 10 7.34±0.46 < 0.001
Fpr1 Formyl peptide receptor 1 7.22±1.18 < 0.001
Cd14 CD14 antigen 7.15±0.47 < 0.001
BIOFILM CELLS INFECTED MICE
Irg1 Immunoresponsive gene 1 42.97±4.79 < 0.001
Clec4e C-type lectin domain family 4, member e 18.49±2.67 < 0.001
Cxcl2 Chemokine (C-X-C motif) ligand 2 18.22±3.27 < 0.001
Slc7a11 Solute carrier family 7, member 11 10.51±2.77 < 0.001
Cxcl10 Chemokine (C-X-C motif) ligand 10 10.24±1.37 < 0.001
Ccrl2 Chemokine (C-C motif) receptor-like 2 8.54±0.47 < 0.001
Clec5a C-type lectin domain family 5, member a 8.61±1.07 < 0.001
Mrgpra2a MAS-related GPR, member A2A 7.68±0.87 < 0.001
Fpr1 Formyl peptide receptor 1 6.59±0.83 < 0.001
Gpr84 G protein-coupled receptor 84 6.18±0.37 < 0.001
is particular and is specified in “microarrays data analysis”
subsection.
RESULTS
Biofilm-Released Cells Induce a Particular
Gene Expression Profile on Mouse
Splenocytes
The transcriptomic profile of mice infected with S. epidermidis
planktonic, biofilm and biofilm-released cells was compared with
that of non-infected mice in order to identify the genes expressed
during infection induced by each of the three populations.
Principal components analysis revealed that infected mice
displayed a markedly different gene expression profile from non-
infected controls (Figure 1A). The differences among infected
mouse groups, however, were not that evident. The genes with
the highest or lowest levels of transcription were similar in the
three groups of infected mice (Tables 1, 2). Nevertheless, despite
these general similarities important differences were found in
the number of genes with increased and decreased transcription
(Figure 1B). Within the 243 genes found differentially expressed
(P < 0.05) in mice infected with biofilm-released cells, 121
were exclusive to this infecting phenotype (Figure 1C), where 96
had increased transcription (above 1.5-fold change) and 25 had
decreased transcription (above −1.5-fold change; Figure 1D).
Among the genes with increased transcription in splenocytes of
mice infected with biofilm-released cells, we found significant
enrichment of several GO clusters (Table 3) including positive
regulation of leukocyte cell-cell adhesion, tumor necrosis factor-
mediated signaling and T cell activation, and negative regulation
of mitogen activated protein kinases (MAPK) cascade and
interleukin-10 production. Interestingly, GO terms associated
with programmed cell death such as regulation of intrinsic
apoptotic signaling pathways, development of cell death, and
cell killing were also enriched. Finally, we observed that the
Frontiers in Microbiology | www.frontiersin.org 5 September 2016 | Volume 7 | Article 1530
França et al. S. epidermidis Biofilm-Released Cells Virulence
TABLE 2 | List of the top less transcribed genes in the spleen of mice infected with S. epidermidis planktonic, biofilm, or biofilm-released cells.
Gene Description Fold change P-value
PLANKTONIC CELLS INFECTED MICE
Abcd2 ATP-binding cassette, sub-family D (ALD), member 2 −5.20 ± 1.41 0.013
Kctd12b Potassium channel tetramerisation domain containing 12b −2.14 ± 0.22 0.038
Mmp12 Matrix metallopeptidase 12 −2.03 ± 0.15 0.038
BIOFILM-RELEASED CELLS INFECTED MICE
Abcd2 ATP-binding cassette, sub-family D (ALD), member 2 −5.31 ± 1.73 0.005
Ccr2 Chemokine (C-C motif) receptor 2 −2.43 ± 0.40 0.017
Sema6a Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A −2.38 ± 0.37 0.014
Kctd12b Potassium channel tetramerisation domain containing 12b −2.35 ± 0.24 0.003
Pcdha7 Protocadherin alpha 7 −2.34 ± 0.30 0.005
Gm3376 Predicted gene 3376 −2.33 ± 0.23 0.004
Rgs2 Regulator of G-protein signaling 2 −2.33 ± 0.39 0.012
Tlr8 Toll-like receptor 8 −2.26 ± 0.36 0.028
Kcnj16 Potassium inwardly-rectifying channel, subfamily J, member 16 −2.17 ± 0.27 0.009
Mmp12 Matrix metallopeptidase 12 −2.18 ± 0.54 0.045
BIOFILM CELLS INFECTED MICE
Abcd2 ATP-binding cassette, sub-family D (ALD), member 2 −4.83 ± 1.66 0.012
Kctd12b Potassium channel tetramerisation domain containing 12b −2.21 ± 0.27 0.013
Sema6a Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A −2.20 ± 0.15 0.012
Rgs2 Regulator of G-protein signaling 2 −2.11 ± 0.21 0.012
Mmp12 Matrix metallopeptidase 12 −2.07 ± 0.03 0.005
Prr5l Proline rich 5 like −1.80 ± 0.15 0.040
Gm13710 Predicted gene 13710 −1.78 ± 0.06 0.016
Vstm4 V-set and transmembrane domain containing 4 −1.76 ± 0.13 0.032
great majority of the transcripts of the genes with increased
expression in mice infected with biofilm-released cells were
those encoding proteins mostly localized to the cytoplasm or
in cells’ organelles (Table 3). No enrichment was found among
down-regulated genes, in any of the conditions tested. For
further information regarding the GO terms found enriched
in mice infected with planktonic or biofilm cells please see
Supplementary Material.
A more comprehensive analysis revealed that within the
greatest transcribed genes in mice infected with biofilm-
released cells are genes with important functions in both
innate and adaptive immune response such as those encoding
the early activation marker CD69, and the co-stimulatory
molecules CD80, CD86, and CD83, which are expressed on
antigen-presenting cells and up-regulated upon exposure to
pathogens. Furthermore, mRNA encoding the cytokine CCL17
or TARC (thymus and activation-regulated chemokine), a T cell
attractant chemokine produced by dendritic cells, was found
significantly up-regulated.
Biofilm-Released Cells Induce Higher
Stimulation of Pro-Inflammatory Cytokines
and Chemokines
As shown in Figure 2, mice infected with biofilm-released cells
had significantly higher serum levels of the chemokines CCL3,
CCL4, and CXCL1, as well as higher levels of TNF-α than mice
infected with planktonic cells, 2 h after the bacterial challenge. At
that time point, no differences were found in the levels of any
assessed cytokines between biofilm and biofilm-released cells-
infected mouse groups. In contrast, 6 h after infection, markedly
higher serum levels of CXCL1, TNFα, and IL-6 were detected
in mice infected with biofilm-released cells than in the biofilm
cell-infected counterparts. By 14 h after infection, lower serum
levels of CCL2 were detected in mice infected with biofilm-
released cells, when compared with their planktonic infected
counterparts. No significant differences were detected in the
serum levels of any other assessed cytokine among the different
infected groups.
Biofilm-Released Cells Present an
Intermediate Ability to Colonize Murine
Organs
Biofilm-released cells had an intermediate ability, between that
of planktonic and biofilm cells, to colonize the liver and spleen
(Figure 3). Interestingly, while in the first 6 h of infection,
biofilm-released cell burden resembled that of planktonic cells,
14 h after infection the differences between planktonic and
biofilm-released cells and the similarities between biofilm-
released and biofilms cells become noticeable. It is important to
note that although the inoculum was adjusted by flow cytometry
the quantity of bacteria injected was also confirmed by CFU
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TABLE 3 | GO term enrichment of the genes with increased transcription in the spleen of mice infected with S. epidermidis biofilm-released cells.
GO ID Cluster representatives N. of genes P-value
BIOLOGICAL PROCESS
GO:2001242 Regulation of intrinsic apoptotic signaling pathway 11 < 0.0001
GO:2000116 Regulation of cysteine-type endopeptidase activity 12 < 0.0001
GO:0043409 Negative regulation of MAPK cascade 9 < 0.0001
GO:1903039 Positive regulation of leukocyte cell-cell adhesion 9 < 0.001
GO:0050870 Positive regulation of T cell activation 8 0.001
GO:0044003 Modification by symbiont of host morphology or physiology 4 0.001
GO:0031329 Regulation of cellular catabolic process 15 0.003
GO:0010623 Developmental programmed cell death 4 0.004
GO:0002260 Lymphocyte homeostasis 5 0.005
GO:0031638 Zymogen activation 6 0.006
GO:0006986 Response to unfolded protein 5 0.007
GO:0031341 Regulation of cell killing 5 0.007
GO:0010243 Response to organonitrogen compound 13 0.007
GO:0032693 Negative regulation of interleukin-10 production 3 0.007
GO:1901698 Response to nitrogen compound 14 0.010
GO:0048646 Anatomical structure formation involved in morphogenesis 18 0.010
GO:0019724 B cell mediated immunity 5 0.011
GO:0035966 Response to topologically incorrect protein 5 0.011
GO:0010727 Negative regulation of hydrogen peroxide metabolic process 2 0.011
GO:0010743 Regulation of macrophage derived foam cell differentiation 3 0.014
GO:0043243 Positive regulation of protein complex disassembly 3 0.014
GO:0033043 Regulation of organelle organization 19 0.016
GO:0009628 Response to abiotic stimulus 16 0.017
GO:0009888 Tissue development 25 0.017
GO:0033209 Tumor necrosis factor-mediated signaling pathway 3 0.020
GO:0042940 D-amino acid transport 2 0.023
GO:0016192 Vesicle-mediated transport 16 0.030
GO:0018149 Peptide cross-linking 3 0.030
GO:0045787 Positive regulation of cell cycle 8 0.030
GO:0061028 Establishment of endothelial barrier 3 0.032
GO:0048147 Negative regulation of fibroblast proliferation 3 0.035
GO:0008637 Apoptotic mitochondrial changes 4 0.038
GO:0034976 Response to endoplasmic reticulum stress 5 0.046
GO:0009314 Response to radiation 9 0.046
GO:0051604 Protein maturation 7 0.047
GO:0051195 Negative regulation of cofactor metabolic process 2 0.048
GO:0048661 Positive regulation of smooth muscle cell proliferation 4 0.048
MOLECULAR PROCESS
GO:0050786 RAGE receptor binding 4 < 0.001
GO:0016209 Antioxidant activity 6 0.005
GO:0048020 CCR chemokine receptor binding 4 0.005
GO:0046983 Protein dimerization activity 24 0.016
GO:0038024 Cargo receptor activity 5 0.038
GO:0042803 Protein homodimerization activity 17 0.046
CELLULAR COMPONENTS
GO:0031988 Membrane-bounded vesicle 50 < 0.001
GO:0043226 Organelle 108 0.002
GO:0043227 Membrane-bounded organelle 116 0.016
GO:0044424 Intracellular part 115 0.017
(Continued)
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TABLE 3 | Continued
GO ID Cluster representatives N. of genes P-value
GO:0005737 Cytoplasm 99 0.017
GO:0005912 Adherens junction 12 0.018
GO:0072559 NLRP3 inflammasome complex 2 0.027
GO:0005622 Intracellular 114 0.032
GO:0005576 Extracellular region 46 0.042
Gene set enrichment was primary assessed with STRING (Franceschini et al., 2013) and then the GO terms only found in this condition were analyzed by REVIGO (Supek et al., 2011)
to reduce redundancy.
counting, and the number of CFU was similar among the
different populations.
DISCUSSION
Due to the significant role of biofilms in the emergence
of nosocomial infections, previous studies have focused on
comparisons between planktonic cultures and established
biofilms in order to highlight particular features of biofilm-
associated infections (Becker et al., 2001; Resch et al., 2005;
Shemesh et al., 2007). The role of biofilm-released cells in
the pathogenesis of biofilm infections is, however, poorly
understood, with no prior studies addressing this issue in regard
to S. epidermidis infection. We have recently shown that biofilm-
released cells, obtained using the same experimental model used
herein, are more tolerant than planktonic cells, or even biofilm
cells, to antibiotics commonly used for staphylococcal infections
treatment (Franca et al., 2016). Nevertheless, nothing is known
about the interplay between these cells and the host immune
system. Hence, we have evaluated the interaction between S.
epidermidis biofilm-released cells and the host immune system,
using planktonic and biofilm cells for comparative purposes. We
first determined whether biofilm-released cells would induce a
different transcriptional profile in splenocytes of mice infected
through the hematogenous route. Transcriptomic data showed
that mice challenged with biofilm-released cells responded
distinctly from the ones infected with the other bacterial
populations. Although, a striking difference was observed
between control and infected mouse groups, less marked
alterations were found within the mouse groups infected with the
three S. epidermidis populations. Since we compared the response
of the host to the same bacterium but in different stages of their
lifecycle, fewer differences among infected groups were expected.
However, a more exhaustive analysis revealed that the expression
level of several genes encoding proteins involved, direct or
indirectly, in the development of innate and adaptive immunity
were significantly increased in biofilm-released cells-infected
mice. An increased transcription of S100a8 and S100a9 genes,
both encoding damage-associated proteins released mainly by
degranulating neutrophils (Simard et al., 2011) and Ly6g, which
encodes a neutrophil surface marker (Lee et al., 2013) were
detected in splenocytes after 2 h of injection of biofilm-released
cells. These mice also had the highest expression of Cxcl2
and Fpr1 encoding, respectively, neutrophil chemoattractant
cytokine CXCL2 (Kobayashi, 2008) and chemotactic receptor
formyl peptide receptor 1 that is also present on neutrophil cell
membranes (Yang and Hwang, 2016). In accordance with the
inflammatory-type response observed in microarrays analysis,
these mice also obtained the highest serum levels of neutrophil
chemo attractant cytokines CXCL1 and CCL3 (Kobayashi, 2008)
2 h after the challenge of biofilm-released cells. These results
indicate that biofilm-released cells may be particularly effective
in promoting neutrophil recruitment and activation. Neutrophils
are very effective in eliminating extracellular bacteria (Nathan,
2006), and therefore the type and magnitude of response elicited
by biofilm-released cells may explain their faster or more
effective clearance from the liver and spleen of infected mice,
as compared to planktonic cells. Moreover, biofilm-released cells
were also more effective at inducing Irg1 expression, a gene
known to be highly expressed in macrophages in response to
infections that limits bacterial survival (Cordes et al., 2015). In
agreement with the pro-inflammatory response elicited, biofilm-
released cell-infected mice showed down-regulated transcription
of the anti-inflammatory cytokine interleukin-10. IL-10 is a key
cytokine in decreasing inflammatory pathology (Saraiva and
O’Garra, 2010), such as that resulting from infection (Duell
et al., 2012) by negatively regulating inflammation (Couper
et al., 2008). The impact of IL-10 repression in the context
of S. epidermidis biofilm-released cells bloodstream infections
would thus be worth to explore. Nevertheless, mice infected
with biofilm cells, were the ones presenting the lowest bacterial
burden although not eliciting the highest pro-inflammatory
response as could be inferred from gene expression or cytokine
levels. A possible explanation for the delayed clearance of
biofilm-released cells as compared to biofilm cells may be an
enhanced apoptosis of immune cells. This is supported by the
significant enrichment of genes associated with this type of
cell death observed in mice infected with biofilm-released cells
such as the Caspase-4, Caspase-8, and FAS-associated death
domain-like apoptosis regulator (Ulett and Adderson, 2006).
Furthermore, enrichment of genes related to the assembly of
the NLRP3 inflammasome complex, which has been associated
in cell apoptosis and pyroptosis (Sagulenko et al., 2013), was
also observed. Interestingly, it was recently shown that during
earlyMycobacterium avium biofilm infection, mononuclear cells
phagocytic function was attenuated due to hyperstimulation of
phagocytes and enhanced cell death by apoptosis induced by
biofilm cells (Rose and Bermudez, 2014). Although, we have
not specifically addressed this phenomenon in S. epidermidis
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FIGURE 2 | Pro-inflammatory cytokines and chemokines induced by the different S. epidermidis populations. BALB/c mice were challenged intravenously
with 1 × 108 planktonic (P), biofilm (B), biofilm-released (BR) cells, or sham-infected treated with PBS alone (PBS). The serum levels of the indicated cytokines were
assessed 2, 6 and 14 h after infection. The obtained results are displayed as the concentration, in ρg/mL, and the horizontal bars represent the median with range of 1
(6 and 14 h time points) to 2 independent (2 h time point) experiments that, per time point, presented the following number of animals: PBS n = 2/2/2; P n = 10/5/5;
BR n = 10/5/5; B n = 10/5/5. Statistical differences among infected groups were evaluated using Kruskal–Wallis (Overall ANOVA P < 0.05) and post hoc Dunn’s
multiple comparison tests. *P < 0.05, **P < 0.01.
biofilm cells-infected mice, our results suggest that it would be
worth investigate in future studies whether biofilm-released cells
may employ a similar strategy to circumvent host inflammatory
response.
Our results also suggest that biofilm-released cells might
be particularly effective in activating antigen-presenting cells,
specifically dendritic cells. This hypothesis is based on the
significant increase in mRNA encoding the T cell co-stimulatory
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FIGURE 3 | Liver and spleen bacterial load after infection with the different S. epidermidis populations. BALB/c mice were challenged intravenously with 1
× 108 planktonic (P), biofilm (B), biofilm-released (BR) cells, or sham-infected treated with PBS alone (PBS). Liver and spleen bacterial burden was assessed 2, 6, and
14 h after intravenous infection. Each symbol represents an individual mouse and horizontal bars the median of 1 (biofilms) to 3 (P and BR, 6h time point) independent
experiments that, per time point, presented the following number of animals: P n = 14/16/11; BR n = 14/16/11; B n = 5/5/5. Statistical differences among groups
were evaluated with Kruskal–Wallis (Overall ANOVA P < 0.05) and post hoc Dunn’s multiple comparison tests. *P < 0.05, **P < 0.01.
molecules CD80 and CD86 (Vasilevko et al., 2002; Sansom
et al., 2003), the CD83 marker of mature dendritic cells
(Lechmann et al., 2008), as well as CCL22 that encodes a
chemokine secreted by both macrophages and dendritic cells
(Yamashita and Kuroda, 2002) and CCL17 (TARC). Although,
CCL17 has been associated with Th2-type responses (Xiao
et al., 2003) how biofilm-released cells might affect T cell
polarization should be determined in functional assays. In
addition, since the spleen comprises cell types other than
myeloid cells, including leukocytes and also non-hematopoietic
cells, that may be able to produce pro-inflammatory mediators
(Fritz and Gommerman, 2011; Bronte and Pittet, 2013), a
better characterization of the cells particularly stimulated by
biofilm-released cells is needed in order to identify the precise
mechanism by which these cells interact with the host immune
system.
It is important to emphasize that in this study only one S.
epidermidis strain was used, and therefore, it was not possible
to assess if these observations are transversal to the species
or a strain-dependent phenomenon. Moreover, biofilm-released
cells distinctive properties, in particular surface antigens, need
to be fully characterized as these seem to have important
consequences in the outcome of biofilm infections constituting
interesting targets. Overall, our results indicate that S. epidermidis
biofilm-released cells interact distinctly than planktonic or
biofilm cells with the host immune system being particularly
effective in inducing the production of pro-inflammatory
cytokines and in stimulating neutrophils and monocytes.
Biofilm-released cells might thus be of particular relevance in
inducing deleterious inflammation frequently associated with
S. epidermidis biofilm infections (Römling and Balsalbre, 2012)
highlighting the urgent need to extend the study of S. epidermidis
biofilm-originated infections by addressing the cells released by
biofilms.
Finally, our findings also raise important concerns
related to the current strategies proposed for the treatment
of staphylococcal biofilm-related infections. The use of
matrix-degrading enzymes, such as dispersin B, which is
capable of dispersing cells from established biofilms (Kaplan,
2010), is one of the most frequently suggested strategies for the
treatment for staphylococcal infections. However, as indicated
by the data presented here, the use of matrix-degrading enzymes
or other compounds leading to biofilm disassembly need to be
carefully considered as biofilm-released cells can heighten the
inflammatory response of the host consequently augmenting
disease severity.
AUTHOR CONTRIBUTIONS
NC, GP, and MV designed the experiments. AF, BP, AC carried
out the laboratory experiments. AF, GP,MV, and NC analyzed the
data, interpreted the results, discussed analyses, interpretation
and presentation. AF, AC, GP, NC, and MV wrote the paper. All
authors have contributed to, seen and approved the manuscript.
FUNDING
This work was supported by European Union funds
(FEDER/COMPETE) and by national funds (FCT) under
the project with reference FCOMP-01-0124-FEDER-014309
(PTDC/BIA-MIC/113450/2009). The authors thank the FCT
Strategic Project of UID/BIO/04469/2013 unit, and the project
RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462).
NC is an Investigator FCT. AF is supported by the FCT
fellowship SFRH/BPD/99961/2014 and AC by the fellowship
SFRH/BPD/91623/2012. The funders had no role in study design,
data collection and interpretation, or the decision to submit the
work for publication.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.01530
Frontiers in Microbiology | www.frontiersin.org 10 September 2016 | Volume 7 | Article 1530
França et al. S. epidermidis Biofilm-Released Cells Virulence
REFERENCES
Becker, P., Hufnagle, W., Peters, G., and Herrmann, M. (2001). Detection of
differential gene expression in biofilm-forming versus planktonic populations
of Staphylococcus aureus using micro-representational-difference analysis.
Appl. Environ. Microbiol. 67, 2958–2965. doi: 10.1128/AEM.67.7.2958-
2965.2001
Boles, B. R., and Horswill, A. R. (2011). Staphylococcal biofilm disassembly. Trends
Microbiol. 19, 449–455. doi: 10.1016/j.tim.2011.06.004
Bronte, V., and Pittet, M. J. (2013). The spleen in local and systemic regulation of
immunity. Immunity 39, 806–818. doi: 10.1016/j.immuni.2013.10.010
Cerca, F., Trigo, G., Correia, A., Cerca, N., Azeredo, J., and Vilanova, M. (2011).
SYBR green as a fluorescent probe to evaluate the biofilm physiological state
of Staphylococcus epidermidis, using flow cytometry. Can. J. Microbiol. 57,
850–856. doi: 10.1139/w11-078
Cerca, N., Jefferson, K. K., Oliveira, R., Pier, G. B., and Azeredo, J. (2006).
Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis
cells grown in a biofilm or in the planktonic state. Infect. Immun. 74,
4849–4855. doi: 10.1128/IAI.00230-06
Cerca, N., Martins, S., Cerca, F., Jefferson, K. K., Pier, G. B., Oliveira, R.,
et al. (2005). Comparative assessment of antibiotic susceptibility of coagulase-
negative staphylococci in biofilm versus planktonic culture as assessed by
bacterial enumeration or rapid XTT colorimetry. J. Antimicrob. Chemother. 56,
331–336. doi: 10.1093/jac/dki217
Chua, S. L., Liu, Y., Yam, J. K., Chen, Y., Vejborg, R. M., Tan, B. G., et al. (2014).
Dispersed cells represent a distinct stage in the transition from bacterial biofilm
to planktonic lifestyles. Nat. Commun. 5:4462. doi: 10.1038/ncomms5462
Cordes, T., Michelucci, A., and Hiller, K. (2015). Itaconic acid: the surprising role
of an industrial compound as a mammalian antimicrobial metabolite. Annu.
Rev. Nutr. 35, 451–473. doi: 10.1146/annurev-nutr-071714-034243
Costerton, J. W., Stewart, P. S., and Greenberg, E. P. (1999). Bacterial biofilms:
a common cause of persistent infections. Science 284, 1318–1322. doi:
10.1126/science.284.5418.1318
Couper, K. N., Blount, D. G., and Riley, E. M. (2008). IL-10: the master
regulator of immunity to infection. J. Immunol. 180, 5771–5777. doi:
10.4049/jimmunol.180.9.5771
Duell, B. L., Tan, C. K., Carey, A. J., Cripps, A. W., and Ulett, G. C. (2012). Recent
insights into microbial triggers of interleukin-10 production in the host and the
impact on infectious disease pathogenesis. FEMS Immunol. Med. Microbiol. 64,
296–313. doi: 10.1111/j.1574-695x.2012.00931.x
Franca, A., Carvalhais, V., Vilanova, M., Pier, G. B., and Cerca, N. (2016).
Characterization of an in vitro fed-batch model to obtain cells released
from S. epidermidis biofilms. AMB Express 6, 23. doi: 10.1186/s13568-016-
0197-9
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth,
A., et al. (2013). STRING v9.1: protein-protein interaction networks, with
increased coverage and integration. Nucleic Acids Res. 41, D808–D815. doi:
10.1093/nar/gks1094
Fritz, J. H., and Gommerman, J. L. (2011). Cytokine/stromal cell networks and
lymphoid tissue environments. J. Interferon. Cytokine Res. 31, 277–289. doi:
10.1089/jir.2010.0121
Kallio, M. A., Tuimala, J. T., Hupponen, T., Klemela, P., Gentile, M., Scheinin, I.,
et al. (2011). Chipster: user-friendly analysis software for microarray and other
high-throughput data. BMC Genomics 12:507. doi: 10.1186/1471-2164-12-507
Kaplan, J. B. (2010). Biofilm dispersal: mechanisms, clinical implications,
and potential therapeutic uses. J. Dent. Res. 89, 205–218. doi:
10.1177/0022034509359403
Kobayashi, Y. (2008). The role of chemokines in neutrophil biology. Front. Biosci.
1, 2400–2407. doi: 10.2741/2853
Kristian, S. A., Birkenstock, T. A., Sauder, U., Mack, D., Gotz, F., and Landmann,
R. (2008). Biofilm formation induces C3a release and protects Staphylococcus
epidermidis from IgG and complement deposition and from neutrophil-
dependent killing. J. Infect. Dis. 197, 1028–1035. doi: 10.1086/528992
Lechmann, M., Shuman, N., Wakeham, A., and Mak, T. W. (2008). The
CD83 reporter mouse elucidates the activity of the CD83 promoter in B,
T, and dendritic cell populations in vivo. Proc. Natl. Acad. Sci. U.S.A. 105,
11887–11892. doi: 10.1073/pnas.0806335105
Lee, P. Y., Wang, J. X., Parisini, E., Dascher, C. C., and Nigrovic, P. A. (2013).
Ly6 family proteins in neutrophil biology. J. Leukoc. Biol. 94, 585–594. doi:
10.1189/jlb.0113014
Li, Y., Petrova, O. E., Su, S., Lau, G. W., Panmanee, W., Na, R., et al.
(2014). BdlA, DipA and induced dispersion contribute to acute virulence and
chronic persistence of Pseudomonas aeruginosa. PLoS Pathog. 10:e1004168. doi:
10.1371/journal.ppat.1004168
Liu, J., Ling, J. Q., Zhang, K., and Wu, C. D. (2013). Physiological properties of
Streptococcus mutansUA159 biofilm-detached cells. FEMSMicrobiol. Lett. 340,
11–18. doi: 10.1111/1574-6968.12066
Mack, D., Nedelmann, M., Krokotsch, A., Schwarzkopf, A., Heesemann, J., and
Laufs, R. (1994). Characterization of transposon mutants of biofilm-producing
Staphylococcus epidermidis impaired in the accumulative phase of biofilm
production: genetic identification of a hexosamine-containing polysaccharide
intercellular adhesin. Infect. Immun. 62, 3244–3253.
Marks, L. R., Davidson, B. A., Knight, P. R., and Hakansson, A. P. (2013).
Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion
and transition from asymptomatic colonization to disease. MBio 4, e00438–
e00413. doi: 10.1128/mBio.00438-13
Nathan, C. (2006). Neutrophils and immunity: challenges and opportunities. Nat.
Rev. Immunol. 6, 173–182. doi: 10.1038/nri1785
Oliveros, J. C. (2007). VENNY. An Interactive Tool for
Comparing Lists with Venn Diagrams. Available online at:
http://bioinfogp.cnb.csic.es/tools/venny/index.html
Otto, M. (2009). Staphylococcus epidermidis–the ‘accidental’ pathogen. Nat. Rev.
Microbiol. 7, 555–567. doi: 10.1038/nrmicro2182
Otto, M. (2012). Staphylococcal infections: mechanisms of biofilm maturation
and detachment as critical determinants of pathogenicity. Annu. Rev. Med. 64,
175–188. doi: 10.1146/annurev-med-042711-140023
Pavlidis, P., and Noble, W. S. (2003). Matrix2png: a utility for visualizing matrix
data. Bioinformatics 19, 295–296. doi: 10.1093/bioinformatics/19.2.295
Pitz, A. M., Yu, F., Hermsen, E. D., Rupp, M. E., Fey, P. D., and
Olsen, K. M. (2011). Vancomycin susceptibility trends and prevalence of
heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical
methicillin-resistant S. aureus isolates. J. Clin. Microbiol. 49, 269–274. doi:
10.1128/JCM.00914-10
Resch, A., Rosenstein, R., Nerz, C., and Gotz, F. (2005). Differential gene
expression profiling of Staphylococcus aureus cultivated under biofilm
and planktonic conditions. Appl. Environ. Microbiol. 71, 2663–2676. doi:
10.1128/AEM.71.5.2663-2676.2005
Rollet, C., Gal, L., and Guzzo, J. (2009). Biofilm-detached cells, a transition from
a sessile to a planktonic phenotype: a comparative study of adhesion and
physiological characteristics in Pseudomonas aeruginosa. FEMSMicrobiol. Lett.
290, 135–142. doi: 10.1111/j.1574-6968.2008.01415.x
Römling, U., and Balsalbre, C. (2012). Biofilm infections, their resilience to
therapy and innovative treatment strategies. J. Intern. Med. 271, 541–561. doi:
10.1111/joim.12004
Rose, S. J., and Bermudez, L. E. (2014). Mycobacterium avium biofilm attenuates
mononuclear phagocyte function by triggering hyperstimulation and apoptosis
during early infection. Infect. Immun. 83, 405–412. doi: 10.1128/IAI.00820-13
Sagulenko, V., Thygesen, S. J., Sester, D. P., Idris, A., Cridland, J. A., Vajhala, P.
R., et al. (2013). AIM2 and NLRP3 inflammasomes activate both apoptotic
and pyroptotic death via ASC. Cell Death Differ. 20, 1149–1160. doi:
10.1038/cdd.2013.37
Sandberg, R., and Larsson, O. (2007). Improved precision and accuracy for
microarrays using updated probe set definitions. BMC Bioinformatics 8:48. doi:
10.1186/1471-2105-8-48
Sansom, D. M., Manzotti, C. N., and Zheng, Y. (2003). What’s the difference
between CD80 and CD86? Trends Immunol. 24, 314–319. doi: 10.1016/S1471-
4906(03)00111-X
Saraiva, M., and O’Garra, A. (2010). The regulation of IL-10 production by
immune cells. Nat. Rev. Immunol. 10, 170–181. doi: 10.1038/nri2711
Shemesh, M., Tam, A., and Steinberg, D. (2007). Differential gene expression
profiling of Streptococcus mutans cultured under biofilm and planktonic
conditions.Microbiology 153, 1307–1317. doi: 10.1099/mic.0.2006/002030-0
Simard, J. C., Simon, M. M., Tessier, P. A., and Girard, D. (2011). Damage-
associated molecular pattern S100A9 increases bactericidal activity of human
Frontiers in Microbiology | www.frontiersin.org 11 September 2016 | Volume 7 | Article 1530
França et al. S. epidermidis Biofilm-Released Cells Virulence
neutrophils by enhancing phagocytosis. J. Immunol. 186, 3622–3631. doi:
10.4049/jimmunol.1002956
Smyth, G. K. (2004). Linear models and empirical bayes methods for assessing
differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol.
3:3. doi: 10.2202/1544-6115.1027
Sousa, C., Franca, A., and Cerca, N. (2014). Assessing and reducing sources
of genes expression variability in Staphylococcus epidermidis biofilms.
Biotechniques 57, 295–301. doi: 10.2144/000114238
Supek, F., Bosnjak, M., Skunca, N., and Smuc, T. (2011). REVIGO summarizes
and visualizes long lists of gene ontology terms. PLoS ONE 6:e21800. doi:
10.1371/journal.pone.0021800
Ulett, G. C., and Adderson, E. E. (2006). Regulation of apoptosis by Gram-
positive bacteria: mechanistic diversity and consequences for immunity. Curr.
Immunol. Rev. 2, 119–141. doi: 10.2174/157339506776843033
Vasilevko, V., Ghochikyan, A., Holterman, M. J., and Agadjanyan, M. G. (2002).
CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation
and maintenance of CD4+ T-cell proliferation after activation with suboptimal
doses of PHA. DNA Cell Biol. 21, 137–149. doi: 10.1089/10445490252925404
von Eiff, C., Peters, G., and Heilmann, C. (2002). Pathogenesis of infections
due to coagulase-negative staphylococci. Lancet Infect. Dis. 2, 677–685. doi:
10.1016/S1473-3099(02)00438-3
Vuong, C., and Otto, M. (2002). Staphylococcus epidermidis infections. Microbes
Infect. 4, 481–489. doi: 10.1016/S1286-4579(02)01563-0
Wang, R., Khan, B. A., Cheung, G. Y., Bach, T. H., Jameson-Lee, M., Kong, K. F.,
et al. (2011). Staphylococcus epidermidis surfactant peptides promote biofilm
maturation and dissemination of biofilm-associated infection in mice. J. Clin.
Invest. 121, 238–248. doi: 10.1172/JCI42520
Xiao, T., Fujita, H., Saeki, H., Mitsui, H., Sugaya, M., Tada, Y., et al. (2003).
Thymus and activation-regulated chemokine (TARC/CCL17) produced by
mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and
downregulated by IFN-gamma. Cytokine 23, 126–132. doi: 10.1016/S1043-
4666(03)00221-7
Yamashita, U., and Kuroda, E. (2002). Regulation of macrophage-derived
chemokine (MDC, CCL22) production. Crit. Rev. Immunol. 22, 105–114. doi:
10.1615/CritRevImmunol.v22.i2.10
Yang, S. C., and Hwang, T. L. (2016). The potential impacts of formyl peptide
receptor 1 in inflammatory diseases. Front. Biosci. (Elite. Ed). 1, 436–449.
Yao, Y., Sturdevant, D. E., and Otto, M. (2005). Genomewide analysis of
gene expression in Staphylococcus epidermidis biofilms: insights into the
pathophysiology of S. epidermidis biofilms and the role of phenol-soluble
modulins in formation of biofilms. J. Infect. Dis. 191, 289–298. doi:
10.1086/426945
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 França, Pérez-Cabezas, Correia, Pier, Cerca and Vilanova. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Microbiology | www.frontiersin.org 12 September 2016 | Volume 7 | Article 1530
